CardieX subsidiary ATCOR reaches technology milestone for world-first PPG sensor algorithm

CardieX Ltd's (ASX:CDX) subsidiary ATCOR has completed a world-first algorithm for a wearable optical sensor, which provides a unique range of cardiovascular health parameters based around ATCOR’s patented SphygmoCor® technology. This major milestone cements the technology algorithm foundation for its CONNEQT Band and other wearables partnerships and signals the commercial readiness of ATCOR’s wearable health analytics platform, Arty™, into consumer wearable devices. Currently, no commercially available wearable device offers the range of individualised health parameters that are available on the Arty platform which provide unique insights into the heart and surrounding arterial systems. Another "technology first" for CardieX CDX chief executive officer Craig Cooper said this marked another technology first for the company. He said: “We were the first to obtain FDA clearance (2001) for our 'gold standard' non-invasive central blood pressure devices - which have since become the predicate device on which all other attempts to replicate our technology have been based. “We were also the first and only company to date to validate our technology in a human study. “And now we are looking towards being the first to not only launch the worlds-first consumer-targeted dual blood pressure monitor, but also the first wearable health band (the CONNEQT Band) with a dual PPG sensor based on our patent application lodged last March.” Other highlights This milestone announcement closely follows ATCOR having recently been selected by Yale University to participate in a clinical trial focused on assessing effectiveness of aspirin for the prevention of pre-eclampsia in women with elevated blood pressure. The trial leveraged ATCOR’s SphygmoCor XCEL device to non-invasively measure central blood pressure, central arterial pressure waveform, pulse wave velocity, as well as other heart health parameters of study subjects. Recently, CardieX’s CONNEQT subsidiary also announced an agreement with LifeQ, where both companies’ joint IP for health biometrics will be included in the upcoming CONNEQT Band. The company also has an agreement with Mobvoi for an upcoming smart wearable device.